It is worth noting that all cases of uterine carcinosarcoma (~ 7%), adrenocortical carcinoma (~ 3.5%) and mesothelioma (> 2%) with gene variation have “amplification” mutation type, while all cases of DLBCL (> 4%) have copy number deletion of CARM1. This evidence concerns the gene CARM1 and adrenal cortex carcinoma.